CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase II Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00183820
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-02T00:08:23.779361+00:00
Published At: 2026-07-01T00:00:00+00:00
Record Updated At: 2026-07-01
Results Posted At: 2026-07-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Testicular Cancer", "Germ Cell Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-01"
protocolSection.identificationModule.nctId: "NCT00183820"
protocolSection.identificationModule.officialTitle: "A Phase II Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-07-01"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.